<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The incidence of anticardiolipin (ACL) antibodies in <z:e sem="disease" ids="C0009782" disease_type="Disease or Syndrome" abbrv="">connective tissue disorders</z:e> other than systemic <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> was investigated in 113 subjects: 68 had <z:hpo ids='HP_0001370'>rheumatoid arthritis</z:hpo>, 23 primary <z:e sem="disease" ids="C1527336" disease_type="Disease or Syndrome" abbrv="">Sjogren syndrome</z:e> and 22 had systemic <z:mp ids='MP_0000612'>sclerosis</z:mp> </plain></SENT>
<SENT sid="1" pm="."><plain>VDRL, thromboplastin time and determination of IgG and IgM ACL antibodies (ELISA) were performed in <z:hpo ids='HP_0000001'>all</z:hpo> subjects </plain></SENT>
<SENT sid="2" pm="."><plain>Overall, 45% of patients were positive for ACL antibodies, mostly of the IgG variety (90%) </plain></SENT>
<SENT sid="3" pm="."><plain>No differences were observed among the investigated diseases </plain></SENT>
<SENT sid="4" pm="."><plain>Positive ACL antibodies were not related to evidence of <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e> nor to clinical characteristics of the different diseases </plain></SENT>
<SENT sid="5" pm="."><plain>These results confirm that ACL antibodies may be present in <z:e sem="disease" ids="C0009782" disease_type="Disease or Syndrome" abbrv="">connective tissue disorders</z:e> other than systemic <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e>, but they do not predict the development of <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e> nor help to characterize the severity of the disease </plain></SENT>
</text></document>